IMPACTO PROGNÓSTICO DO PADRÃO DE EXPRESSÃO DE EZH2 EM NEOPLASIA MIELODISPLÁSICA
2023 · Hematology Transfusion and Cell Therapy · 0 citations
https://doi.org/10.1016/j.htct.2023.09.824
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
0
Citations
0
h-index
0
i10-index
BF Silva is an academic researcher from Instituto Nacional do Câncer. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research & Lymphoma Diagnosis and Treatment.
https://doi.org/10.1016/j.htct.2023.09.824
https://doi.org/10.1016/j.htct.2024.09.748
https://doi.org/10.1016/j.htct.2024.09.749
Click to start Chat